The University of Valencia submits a patent application for a vaccine against COVID-19
The University of Valencia has filed a patent application for a vaccine candidate against COVID-19, developed by a research team from the Department of Microbiology. It is a subunit type vaccine (those designed from components of viruses or bacteria) and is based on the SARS-CoV-2 protein S.
16 de may de 2020
A feature of this development is that the main researcher did not wait to obtain research funds to develop the vaccine. In view of the need for a vaccine against SARS-CoV-2, Jesús Rodríguez allocated research funds obtained from compatible funding sources (contracts with companies) to pay for the experiments necessary to reach this research result. This is why a patentable vaccine has been reached so quickly. However, Rodríguez remarks: “there are still many experiments to be carried out to test their efficacy and safety in animals before being able to go on to human studies”.